Acotec Scientific Releases 2026 Interim Report; Implements Full Electronic Distribution Under HKEX Paperless Regime

Bulletin Express
09/23

Acotec Scientific Holdings Limited (Acotec) has published its 2026 Interim Report in both English and Chinese on the HKEXnews platform and the company’s website. The document is immediately accessible at www.hkexnews.hk and www.acotec.cn.

In alignment with the paperless listing regime that took effect on 31 December 2023 (HKEX Listing Rule 2.07), Acotec confirmed that all future corporate communications—including annual and interim reports, meeting notices, listing documents, circulars and proxy forms—will be disseminated exclusively via electronic means.

Key operational changes for shareholders: • Email registration urged: Registered shareholders are requested to provide a functional email address by scanning the personalized QR code on the enclosed reply form or by returning the form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. • Default arrangement: Absent a valid email address, shareholders will not receive electronic notifications. Instead, the company will post printed notices and actionable corporate communications until an email address is supplied. • Printed copies on demand: Shareholders experiencing access difficulties may request hard copies of the current or future corporate communications free of charge by emailing acotec.ecom@computershare.com.hk or writing to Computershare at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong. Such requests remain valid for one year from receipt.

Enquiries regarding the new dissemination model can be directed to the share registrar’s hotline at (+852) 2862 8688 during Hong Kong business hours.

The board-approved notice was signed by Executive Director, Chairperson, and Chief Executive Officer Jing Li on 24 September 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10